Loading...

1933 Industries Inc.

TGIF.CNCNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.01
CA$0.00(0.00%)

1933 Industries Inc. (TGIF.CN) Financial Performance & Income Statement Overview

View comprehensive annual and quarterly summaries for 1933 Industries Inc. (TGIF.CN), featuring income statements, balance sheets, and cash flow data.

Revenue Growth
5.90%
5.90%
Operating Income Growth
100.00%
100.00%
Net Income Growth
91.45%
91.45%
Operating Cash Flow Growth
210.77%
210.77%
Operating Margin
12.61%
12.61%
Gross Margin
16.31%
16.31%
Net Profit Margin
-3.01%
3.01%
ROE
13.10%
13.10%
ROIC
19.11%
19.11%

1933 Industries Inc. (TGIF.CN) Income Statement & Financial Overview

Review 1933 Industries Inc. TGIF.CN income statement with detailed quarterly and annual figures.

MetricQ2 2025Q1 2025Q4 2024Q3 2024
Revenue$4.41M$3.99M$4.23M$4.87M
Cost of Revenue$2.90M$2.69M$6.71M$3.30M
Gross Profit$1.51M$1.31M-$2.49M$1.56M
Gross Profit Ratio$0.34$0.33-$0.59$0.32
R&D Expenses$0.00$0.00$0.00$0.00
SG&A Expenses$503141.00$701065.00$550172.00$935796.00
Operating Expenses$797730.00$749850.00-$2.49M$935796.00
Total Costs & Expenses$3.70M$3.44M$4.23M$4.24M
Interest Income$0.00$0.00$0.00$0.00
Interest Expense$582872.00$840824.00$0.00$486014.00
Depreciation & Amortization$265530.00$258498.00$538357.00$655538.00
EBITDA$535031.00$521493.00-$1.58M$1.22M
EBITDA Ratio$0.12$0.13-$0.37$0.25
Operating Income$714552.00$557589.00$0.00$627630.00
Operating Income Ratio$0.16$0.14$0.00$0.13
Other Income/Expenses (Net)-$1.03M-$1.14M-$1.21M-$545451.00
Income Before Tax-$313370.00-$577829.00-$1.21M$82179.00
Income Before Tax Ratio-$0.07-$0.14-$0.29$0.02
Income Tax Expense$0.00$0.00-$1.63M$0.00
Net Income-$328033.00-$587031.00$8575.00$16694.00
Net Income Ratio-$0.07-$0.15$0.002$0.003
EPS-$0.001-$0.001$0.00$0.00
Diluted EPS-$0.001-$0.001$0.00$0.00
Weighted Avg Shares Outstanding$490.47M$490.47M$490.47M$490.47M
Weighted Avg Shares Outstanding (Diluted)$490.47M$490.47M$490.47M$490.47M

Over the last four quarters, 1933 Industries Inc.'s revenue moved from $4.87M in Q3 2024 to $4.41M in Q2 2025. Operating income in Q2 2025 was $714552.00, with a strong operating margin of 16%. Despite fluctuations in R&D and SG&A expenses, EBITDA for 1933 Industries Inc. remained robust at $535031.00, reflecting operational efficiency. Net income rose to -$328033.00, with an EPS of -$0.001. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;